Ausgabe 3/2022
Inhalt (20 Artikel)
An overview of genetic services delivery for hereditary breast cancer
- Review
Sonya Reid, Lucy B. Spalluto, Katie Lang, Anne Weidner, Tuya Pal
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
- Preclinical study
Phuong Dinh, J. Dinny Graham, Elisabeth N. Elder, Masrura Kabir, Tram B. Doan, James French, Farid Meybodi, Rina Hui, Nicholas R. Wilcken, Paul R. Harnett, Jeremy Hsu, Kirsty E. Stuart, Tim Wang, Verity Ahern, Meagan Brennan, Stephen B. Fox, Rachel F. Dear, Elgene Lim, Michelle White, G. Bruce Mann, Nirmala Pathmanathan
A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA
- Preclinical study
Christopher G. Verdone, Jennifer A. Bayron, Cecilia Chang, Chihsiung E. Wang, Elin R. Sigurdson, Allison A. Aggon, Andrea Porpiglia, Maureen V. Hill, Mary T. Pronovost, Richard J. Bleicher
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R
- Clinical trial
Yapeng Li, Xueying Zheng, Dongsheng Tu, James N. Ingle, Paul E. Goss, Wendy R. Parulekar, Guoyou Qin
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
- Open Access
- Clinical trial
Faye Coe, Vivek Misra, Yamini McCabe, Helen Adderley, Laura Woodhouse, Zaheen Ayub, Xin Wang, Sacha Howell, Maria Ekholm
Factors related to patient-reported cosmetic outcome after breast-conserving therapy for breast cancer
- Clinical trial
A. T. P. M. Brands-Appeldoorn, R. C. M. Thomma, L. Janssen, A. J. G. Maaskant-Braat, V. C. G. Tjan-Heijnen, R. M. H. Roumen
The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer
- Zur Zeit gratis
- COVID-19
- Clinical trial
Dieuwke R. Mink van der Molen, Claudia A. Bargon, Marilot C. T. Batenburg, Lilianne E. van Stam, Iris E. van Dam, Inge O. Baas, Miranda F. Ernst, Wiesje Maarse, Maartje Sier, Ernst J. P. Schoenmaeckers, Thijs van Dalen, Rhodé M. Bijlsma, Annemiek Doeksen, Femke van der Leij, Danny A. Young-Afat, Helena M. Verkooijen
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
- Open Access
- Clinical trial
Nicholas Turner, Rebecca A. Dent, Joyce O’Shaughnessy, Sung-Bae Kim, Steven J. Isakoff, Carlos Barrios, Shigehira Saji, Igor Bondarenko, Zbigniew Nowecki, Qinshu Lian, Sarah-Jayne Reilly, Heather Hinton, Matthew J. Wongchenko, Bruno Kovic, Aruna Mani, Mafalda Oliveira
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort
- Clinical trial
M. Bringuier, M. Carton, C. Levy, A. Patsouris, D. Pasquier, M. Debled, O. Rigal, W. Jacot, A. Gonçalves, I. Desmoulins, T. De La Motte Rouge, T. Bachelot, J.-M. Ferrero, J.-C. Eymard, M. Ung, M.-A. Mouret-Reynier, T. Petit, M. Chevrot, L. Uwer, C. Courtinard, J.-S. Frenel, A. Vianzone, C. Baldini
Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?
- Open Access
- Clinical trial
Benedikt Schaefgen, Annika Funk, H.-P. Sinn, Thomas Bruckner, Christina Gomez, Aba Harcos, Anne Stieber, Annabelle Haller, Juliane Nees, Riku Togawa, André Pfob, André Hennigs, Johanna Hederer, Fabian Riedel, Sarah Fastner, Christof Sohn, Jörg Heil, Michael Golatta
A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes
- Clinical trial
Tae-Kyung Yoo, Jun Kang, Awon Lee, Byung Joo Chae
Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study
- Open Access
- Epidemiology
Sixten Harborg, Thomas P. Ahern, Maria Feldt, Ann H. Rosendahl, Deirdre Cronin-Fenton, Olle Melander, Signe Borgquist
A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer
- Epidemiology
Nickolas Dreher, Madeline Matthys, Edward Hadeler, Yiwey Shieh, Irene Acerbi, Fiona M. McAuley, Michelle Melisko, Martin Eklund, Jeffrey A. Tice, Laura J. Esserman, Laura J. van’t Veer
Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning
- Epidemiology
Kelly A. Metcalfe, Andrea Eisen, Frances Wright, Aletta Poll, Alexandra Candib, David McCready, Tulin Cil, Susan Armel, Yael Silberman, Sarah Brennenstuhl, Steven A. Narod
Studying the association between breast cancer and renal cell carcinoma
- Epidemiology
Khalid Jazieh, Firas Baidoun, Nataly Torrejon, Zahi Merjaneh, Anas Saad, Mohamed Gad, Amal Farouk, Moshe Ornstein, Jame Abraham
Neighborhood characteristics and breast tumor methylation: using epigenomics to explore cancer outcome disparities
- Epidemiology
Jazib Gohar, Whitney L. Do, Jasmine Miller-Kleinhenz, Karen Conneely, Uma Krishnamurti, Olivia D’Angelo, Keerthi Gogineni, Mylin Torres, Sheryl Gabram-Mendola, Lauren E. McCullough
Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system
- Zur Zeit gratis
- COVID-19
- Epidemiology
Annie Tang, Elad Neeman, Brooke Vuong, Vignesh A. Arasu, Raymond Liu, Gillian E. Kuehner, Alison C. Savitz, Liisa L. Lyon, Prachi Anshu, Samantha A. Seaward, Milan D. Patel, Laurel A. Habel, Lawrence H. Kushi, Margaret Mentakis, Eva S. Thomas, Tatjana Kolevska, Sharon B. Chang
Yield of flow cytometry in addition to cytology for lymph node sampling in patients with incidental axillary adenopathy without a concurrent diagnosis of primary breast malignancy
- Epidemiology
Roberto Lo Gullo, Christophe Cloutier Lambert, Oscar Lin, Maxine S. Jochelson, Donna D’Alessio
Safety of systemic hormone replacement therapy in breast cancer survivors
- Letter to the Editor
Avrum Z. Bluming